Dominance of CD86, transforming growth factor-β1, and interleukin-10 in Mycobacterium tuberculosis secretory antigen-activated dendritic cells regulates T helper 1 responses to mycobacterial antigens

Journal of Infectious Diseases

Volumn 189, Issue 9, 2004, Pages 1598-1609

  Balkhi, Mumtaz Yaseen ^a   Sinha, Aprajita ^a   Natarajan, Krishnamurthy ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CELL EXTRACT; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; MONOCLONAL ANTIBODY; MYCOBACTERIUM ANTIGEN; MYCOBACTERIUM TUBERCULOSIS SECRETORY ANTIGEN; SECRETORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; FEMALE; INFLAMMATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TH1 CELL;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD86; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 2342635727     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/383328     Document Type: Article

References (55)

1. World Health Organization (WHO). Fact sheet. Geneva: WHO, 2002.
2. Colditz GA, Brewer FT, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analyses of the published literature. JAMA 1994; 271:698-702.
3. Kaufmann SH. Is the development of a new tuberculosis vaccine possible? Nat Med 2000; 6:955-60.
4. Fine PE. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346:1339-45.
5. Hess JH, Schaible UE, Raupach B, Kaufmann SHE. Exploiting the immune system: towards new vaccines against intracellular bacteria. Adv Immunol 2000; 75:1-8.
6. Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis - persistence, patience, and winning by waiting. Nat Med 2000; 6:1327-9.
7. Foote S. Mediating immunity to mycobacteria. Nat Genet 1999; 21: 345-6.
8. Flynn JA, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19:93-129.
9. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
10. Steinman RM. Dendritic cells. In: Paul WE, ed. Fundamental immunology. Philadelphia: Lippincott-Raven, 1999:547-73.
11. Reid SD, Penna G, Adorini, L. The control of T cell responses by dendritic cell subsets. Curr Opin Immunol 2000; 12:114-21.
12. Sousa CR. Dendritic cells as sensors of infection. Immunity 2001; 14: 495-8.
13. Colangeli R, Spencer JS, Bifani P, et al. MTSA-10, the product of Rv3874 gene of Mycobacterium tuberculosis, elicits tuberculosis-specific, delayed-type hypersensitivity in guinea pigs. Infect Immun 2000; 68:990-3.
14. Latchumanan VK, Singh B, Sharma P, Natarajan K. Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. J Immunol 2002; 169:6856-64.
15. Natarajan K, Latchumanan VK, Singh B, Singh S, Sharma P. Down-regulation of T helper 1 responses to mycobacterial antigens due to maturation of dendritic cells by 10-kDa Mycobacterium tuberculosis secretory antigen. J Infect Dis 2003; 187:914-28.
16. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
17. Vijayakrishnan L, Natarajan K, Manivel V, Raisuddin S, Rao KV. B cell responses to a peptide epitope. IX. The kinetics of antigen binding differentially regulates costimulatory capacity of activated B cells. J Immunol 2000; 164:5605-14.
18. Sahoo NC, Rao KV, Natarajan K. CD80 expression is induced on activated B cells following stimulation by CD86. Scand J Immunol 2002; 55:577-84.
19. Kalinski P, Hilkens CM, Weirnenga EA, Kapsenberg ML. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol Today 1999; 20:561-7.
20. Kournilsky P, Truffa-bachi P. Cytokine fields and the polarization of the immune response. Trends Immunol 2001; 22:502-9.
21. Freedman, AS, Freedrnan GJ, Rhynhart K, Nadler LM. Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. Cell Immunol 1991; 137:429-37.
22. Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol 1997; 159:635-43.
23. Bodnar KA, Serbina NV, Flynn JL. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect Immun 2001; 69:800-9.
24. Demangel C, Palendira U, Feng CG, Heath AW, Bean AG, Britton WJ. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infect Immun 2001; 69:2456-61.
25. Demangel C, Bean AG, Martin E, Feng CG, Kamath AT, Britton WJ. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guerin-infected dendritic cells. Eur J Immunol 1999; 29:1972-9.
26. Hertz CJ, Kiertscher SM, Godowski PJ, et al. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol 2001; 166:2444-50.
27. Anderson P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994; 62:2536-44.
28. Roberts AD, Sonnenberg MG, Ordway DJ, et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 1995; 85:502-8.
29. Roche PW, Triccas JA, Avery DT, Fifts T, Billman-Jacobe H, Britton WJ. Differential T cell responses to mycobacterial secreted proteins distinguish between vaccination with bacillus Calmette Guerin (BCG) and infection with Mycobacterium tuberculosis. J Infect Dis 1994; 170: 1326-30.
30. Andersen PA, Andersen P, Sorenson L, Nagai S. Recall of long lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995; 154:3359-72.
31. Brandt L, Elhay M, Rosenkrands I, Lindblad EB, Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 2000; 68:791-5.
32. Elhay MJ, Oettinger T, Andersen P. Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun 1998; 66:3454-6.
33. Oettinger T, Andersen AB. Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv. Infect Immun 1994; 62:2058-64.
34. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and its absence in Mycobacterium bovis BCG. Infect Immun 1996; 64:16-22.
35. Sorensen A, Nagai LS, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995; 63:1710-7.
36. Haga S, Yamaguchi R, Nagai S, Matsuo K, Yamazaki A, Nakamura RM. Delayed-type hypersensitivity to a recombinant mycobacterial antigen, MPB64, in guinea pigs sensitized by Mycobacterium tuberculosis or Mycobacterium bovis BCG. J Leukoc Biol 1995; 57:221-5.
37. Roche PW, Winter N, Triccas JA, Feng CG, Britton WJ. Expression of Mycobacterium tuberculosis MPT64 in recombinant Mycobacterium smegmatis: purification, immunogeneticity and application to skin tests for tuberculosis. Clin Exp Immunol 1996; 103:226-32.
38. Ratliff TL, McGarr JA, Abou-Zeid C, et al. Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol 1988; 134:1307-13.
39. Tanghe A, D'Souza S, Rosseels V, et al. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun 2001; 69:3041-7.
40. Kamath AT, Hanke T, Briscoe H, Britton WJ. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis. Immunology 1999; 96:511-6.
41. Beatty WL, Russel DG. Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect Immun 2000; 68:6997-7002.
42. Pieters J. Entry and survival of pathogenic mycobacteria in macrophages. Microbes Infect 2001; 3:249-55.
43. Dillon DC, Alderson MR, Day CH, et al. Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG. J Clin Microbiol 2000; 38:3285-90.
44. Lewis KN, Liao R, Guinn KM, et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 2003; 187:117-23.
45. Lenchow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
46. Yoshinaga SK, Whoriskey JS, Khare SD, et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 1999; 402:827-32.
47. Swallow MM, Wallin JJ, Sha WC. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNF-α. Immunity 1999; 11:423-32.
48. Ling V, Wu P, Finnerty HF. Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J Immunol 2000; 164:1653-7.
49. Willems FA, Merchant A, Delville JP, et al. Interleukin-10 inhibits B7 and intercellular adhesion molecule-I expression on human monocytes. Eur J Immunol 1994; 24:1007-9.
50. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting upregulation of B7 expression. J Immunol 1993; 151:1224-34.
51. Lateef Z, Fleming S, Halliday G, Faulkner L, Mercer A, Baird M. Orf virus-encoded interleukin-10 inhibits maturation, antigen presentation and migration of murine dendritic cells. J Gen Virol 2003; 84:1101-9.
52. Tobian AAR, Potter NS, Ramachandra L, et al. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003; 171: 1413-22.
53. Dahl KE, Shiratsuchi H, Hamilton BD, Ellner JJ, Toossi Z. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Inflect Immun 1996; 64:399-405.
54. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth fector β. Proc Natl Acad Sci USA 1997; 94:3926-31.
55. Souji R, Matsumoto M, Tekeuchi O, et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of Toll-like receptors. Infect Immun 2000; 68:6883-90.